Picture of Biosenic SA logo

BIOS Biosenic SA Cashflow Statement

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapTurnaround

Annual cashflow statement for Biosenic SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
R2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSPRESSPRESS
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-12-2.32-7.04-3.1620.9
Depreciation
Non-Cash Items-1.42-0.001-0.3071.11-22.4
Other Non-Cash Items
Changes in Working Capital0.4730.3493.630.7730.417
Change in Accounts Receivable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-12.8-1.91-3.47-1.28-1.05
Capital Expenditures-0.207-0.005
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0031.960.0060.0310.029
Sale of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-0.2041.950.0060.0310.029
Financing Cash Flow Items-1-0.203-0.304-1.230
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities7.851.041.741.550.747
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-5.141.09-1.730.294-0.275